We have discovered that by harnessing the power of tears to determine blood glucose levels NovioSense will free diabetics from the painful finger prick. We have reimagined the way diabetic patients measure glucose. We have redesigned the traditional finger prick glucose sensor into a NovioSense. NovioSense is a small flexible device that sits in the lower eyelid. The device is wirelessly powered and compatible with NFC enabled smart phones
By reimagining the finger strip technology into a new form factor our non-invasive device will allow patients to monitor glucose levels on demand not only non-invasively but also unobtrusively. We have discovered that tears are a unique source of biomarkers with excellent prediction of blood biomarker levels. Armed with this knowledge we have developed a non-invasive sensor capable of detecting trace levels of glucose in tears and accurately extrapolating these values back to blood glucose levels.
Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is overwhelming people and health care systems worldwide.
NovioSense was finalist in this years NWO start-up of the year award. Jan Lauko and Mila Svechtarova compete and accept the award at the Chains Conference 2014.
Finger Prick Glucose
The majority of diabetics have a painful daily reminder of their disease in the form of a finger prick.
The NovioSense Approach
At NovioSense we believe that glucose monitoring can be painless and unobtrusive.